SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as the community debates whether the sell-off is an overreaction to increased AI spending and a one-time tax charge, especially after the company's earnings beat. Many are calling it a buying opportunity, while others express concerns about the long-term impact of Meta's AI investments and increased debt. The stock's potential for a V-shaped recovery and a return to previous price levels is a key talking point.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

RDDT is trending as investors discuss potential earnings outcomes and AI partnerships, with the report coming after the close. Community members are weighing bullish and bearish perspectives, with some pointing to ad revenue trends while others highlight concerns about user growth and valuation. META's recent performance is influencing sentiment, with some drawing comparisons and others emphasizing RDDT's unique position.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle ($CMG) is trending downwards as discussions center on a recent sales outlook cut and concerns about slowing customer traffic, particularly among younger, lower-income demographics. Community sentiment is mixed, with some viewing the dip as a buying opportunity while others cite issues like high prices, shrinking portions, and inconsistent quality as reasons for the decline. The broader context involves concerns about consumer spending and potential recessionary pressures affecting the restaurant sector.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

MRNA is trending amid buyout rumors and discussions of its valuation relative to other tech companies. The community is also focused on the potential for acquisition and the stock's short interest, with some anticipating a significant price increase. Some investors are also discussing news of new cancer treatments.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent BioSolutions is trending amid increased FY25 EBITDA guidance, leading to community discussions around potential re-rating and short squeeze scenarios. Bullish investors are pointing to the company's perceived undervaluation and are hoping to see a short squeeze. Some community members believe that this stock is a feel good story because it is saving lives.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific is trending due to shareholders voting down the proposed merger with CoreWeave, sparking debate about the company's future and valuation; some investors believe CORZ is worth more as an independent entity, citing its AI infrastructure potential, while others worry about the company's financial stability without the merger; community discussions revolve around potential price targets, executive leadership, and future contracts.

Why Queen Kitty ($QKitty) Is The Meme Token You’ve Been Waiting For  Queen Kitty isn’t just another hype project—this is a real movement with substance and community power!  Why hold $QKitty? 😼 Real dev, real builds: No fake teams, no copy-paste code. Everything you see is made from scratch. 💧 Working Faucet: Free QKitty for the community. Want to know how? Just ask! 🏆 Big Buy Competition Bot: See top buyers live, fight for the throne, and win rewards! 🎮 Multi-token P2E game coming soon: Play and earn across Web, iOS, Android! 🐾 NFT collecting soon: Cutest collection in crypto, bringing perks and more ways to earn.  Queen Kitty means innovation, transparency, and real delivery for holders. Curious? Join the chat and ask anything!  $QKitty: By the community, for the community. To the moon, together! 🚀🐱

Queen Kitty

Queen Kitty ($QKITTY) is gaining attention, particularly within the Solana ecosystem, with the community eagerly awaiting the DEX and SWAP release.  Many are highlighting the potential of its trading bot, which is incentivizing holders. Community members are also actively sharing content and expressing bullish sentiment.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv ($FI) is trending downwards amid discussions of a recent earnings miss and lowered guidance, with some community members speculating about potential fraud and comparing the situation to past stock crashes. The community is debating whether the dip presents a buying opportunity due to the company's fundamentals and institutional ownership, or if further declines are expected. Analyst downgrades and management changes add to the uncertainty surrounding the financial services company.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

TDOC is trending as investors discuss its potential for a turnaround, citing undervaluation and upcoming earnings as potential catalysts. Community members are weighing in on potential buyouts, AI integration, and the impact of broader market forces on the stock. Discussions also highlight the company's large user base and significant cash flow, fueling speculation about future growth and value.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors digest its earnings report, with community discussions focusing on the implications of increased AI spending and Azure's growth. Despite strong earnings, the stock's movement reflects broader market concerns about capital expenditure and future growth prospects in the tech sector. Bullish sentiment remains given the company's position in cloud and AI, but some are wary.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Beyond Tesla: Why GM and Ford Heavy ETFs Could Be Safer Bets Now?

GM and Ford-focused ETFs like RPV, MADE, and COWZ may offer investors stability as Tesla faces a post-subsidy demand cliff.  

Should Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?

Is Pacer US Cash Cows 100 ETF (COWZ) a Strong ETF Right Now?

Why Free Cash Flow Drives Superior Stock Performance

Here's why companies with high free cash flow often demonstrate high quality.

Shares of Gilead Sciences, Inc. dropped nearly 2.5% on Wednesday and extended losses after hours following a report that the Health and Human Services Department, led by Robert F. Kennedy Jr., plans to "drastically" cut federal funding for domestic HIV prevention.While cuts have not been finalized, the Wall Street Journal&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/health/healthcare/trump-administration-weighing-major-cuts-to-funding-for-domestic-hiv-prevention-8dcad39b?mod=Searchresults_pos1&amp;page=1&amp;mod=article_inline&amp;adobe_mc=MCMID%3D74537243080012175182679892959762943330%7CMCORGID%3DCB68E4BA55144CAA0A4C98A5%2540AdobeOrg%7CTS%3D1742440495&amp;_gl=1*1myqz7*_gcl_au*NTUzNDY5MDY4LjE3MzUyMTA0MzI.*_ga*MTg1Mzg3MjI1NS4xNzE4OTcyNDYz*_ga_K2H7B9JRSS*MTc0MjQ0MDIzNy4yNi4xLjE3NDI0NDA0OTMuNjAuMC4w">reported</a>, citing people familiar with the matter, that they could be announced soon as part of the Trump administration's broader budget reductions at the Centers for Disease Control and Prevention.Gilead, which has a portfolio of HIV prevention treatments such as Biktarvy and Descovy, risks a hit to revenues if the report turns out to be true.However, retail investors and Wall Street analysts remain largely unfazed for now.Retail sentiment for Gilead on Stocktwits climbed further into the 'extremely bullish' zone on Wednesday, with message volume up 57% following the news.&nbsp;<figure class="image"><img style="aspect-ratio:1318/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/GILD_sentiment_and_message_volume_as_of_March_19_png_baa27803b8.webp" alt="GILD sentiment and message volume as of March 19.png" width="1318" height="302"><figcaption>GILD sentiment and message volume as of March 19. | source: Stocktwits</figcaption></figure>Observers on the platform cited Gilead's dominance in HIV treatments, growing oncology presence, and strong free cash flow as reasons to hold on to the stock.<stembedurl>https://stocktwits.com/Bitcoin333/message/608542775</stembedurl><stembedurl>https://stocktwits.com/skcots131313/message/608543583</stembedurl>According to The Fly, JPMorgan acknowledged that the WSJ report is "clearly not a positive" but says the potential cuts wouldn't impact access to PrEP (pre-exposure prophylaxis). The firm noted that the CDC doesn't reimburse PrEP drugs but funds research and education.&nbsp;The research firm remains bullish on Gilead's lenacapavir — a twice-yearly injectable HIV-1 capsid inhibitor — as a key growth driver and maintains an 'Overweight' rating on the stock.Oppenheimer sees Gilead's pullback as a reaction to uncertainty but doesn't view the funding concerns as a material risk. The firm estimates PrEP revenues account for just 8% of Gilead's total sales, with Medicaid representing an even smaller fraction.&nbsp;It expects early lenacapavir adoption mostly from private insurers and reiterated an 'Outperform' rating with a $132 price target.If approved by the Food and Drug Administration, Morgan Stanley reportedly estimates that lenacapavir could generate annual sales of over $6 billion by 2030.According to Koyfin data, Gilead stock currently trades at a 13.5x forward earnings multiple, compared to Eli Lilly's 36.1x and Amgen's 15.3x.Shares of Gilead are up 16% this year, outperforming the NASDAQ Biotechnology Index's 3% gain.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Gilead Sciences company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Gilead Stock Wobbles On Federal HIV Funding Cut Buzz, But Retail And Analysts Stay Unfazed

The company has a portfolio of HIV prevention treatments such as Biktarvy and Descovy.

Equity

The company has a portfolio of HIV prevention treatments such as Biktarvy and Descovy.


HP, Inc. (<a class="mention" data-mention="$HPQ" data-symbol-id="HPQ" href="https://stocktwits.com/symbol/HPQ" target="_blank">$HPQ</a>) shares fell sharply in Wednesday’s premarket session after the Palo Alto-based company announced fiscal year 2024 fourth-quarter results roughly in line with expectations and running quarter guidance that trailed, reflecting the ongoing weakness in the global PC industry.&nbsp;The manufacturer of personal computing, printing, 3D printing, and gaming products, said its fourth-quarter non-GAAP earnings per share came in at $0.93, within the guidance range of $0.89-$0.99 and in line with the consensus.Net revenue rose a modest 1.7% year-over-year (YoY) to $14.1 billion compared to the $13.99&nbsp;billion consensus estimate. Personal systems net revenue climbed 2% to $9.6 billion,&nbsp;representing around 68% of the total, and printing net revenue was up 1%.Estimates from Gartner&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.gartner.com/en/newsroom/press-releases/2024-10-09-gartner-says-worldwide-pc-shipments-declined-1-percent-in-third-quarter-of-2024">showed</a> global PC shipments falling 1.3% YoY to 62.9 million units in the third quarter, with HP’s shipments seeing a marginal YoY drop.Enrique Lores, HP President and CEO, said, "We are pleased with our Q4 performance where we saw revenue growth for the second consecutive quarter, driven by steady progress in Personal Systems and Print."HP said it returned $1.2 billion to shareholders in the form of share repurchase and dividends.&nbsp;The company announced a 5% increase to its annual dividend. The board declared a $0.2894 quarterly dividend, payable on Jan. 2, 2025, to shareholders of record as of Dec. 11, 2024.Looking ahead, HP expects non-GAAP EPS of $0.70-$0.76 for the first quarter of the fiscal year 2025 and $3.45-$3.75 for the full year. Analysts, on average, expect the metrics to come in at $0.82 and $3.60, respectively.&nbsp;CFO Karen Parkhill said, “As we look ahead, we are well positioned to deliver solid growth across revenue, non-GAAP net earnings, EPS and free cash flow in FY25.”As of 8:30 a.m. ET in premarket trading, HP shares were trading down 8.26% at $35.87. The stock, though, has gained over 33% so far this year.<figure class="image"><a href="https://stocktwits.com/symbol/HPQ"><img style="aspect-ratio:630/131;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/hp_sentiment_df3a5935b3.png" alt="hp-sentiment.png" width="630" height="131"></a><figcaption>HP sentiment and message volume November 25, 2024, premarket as of 8:30 am ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits platform, sentiment toward the stock flipped to ‘extremely bearish’ (5/100) from ‘extremely bullish,’&nbsp;marking a year-low. Meanwhile, message volume&nbsp;climbed further into the&nbsp;‘extremely high’&nbsp;(97/100) territory, the highest it has been this year.Rival Dell Technologies, Inc. ($DELL), despite the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dell-q3-2025-earnings-beat-estimates-revenue-trails/cJI0ul9RW3">post-earnings plunge,</a> was viewed more positively by retailers, given its exposure to artificial intelligence servers.&nbsp;For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>&nbsp;Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rambus-initiated-at-outperform-at-baird/cJIWrizRgU">Rambus Stock Powers Up After Memory Chipmaker Snags A Bullish Rating: Retail Upbeat</a>

Global PC shipments fell 1.3% YoY in Q3, according to Gartner.

HP Q4 Results Deflate Retail Mood: Stock Sinks Over 8% As In-Line Quarterly Results, Sub-par Guidance Worry Traders

HP reported low single-digit revenue growth for its personal systems as well as printing segments.

ZoomInfo Technologies, Inc. ($ZI), a B2B platform that offers a commercial search-engine for companies and businesses, reported third-quarter results that exceeded expectations and issued fairly in-line guidance for the fourth quarter and the full year.Vancouver, Washington-based ZoomInfo reported third-quarter non-GAAP earnings per share of $0.28, up from $0.26 earned a year-ago. The bottom-line result exceeded the consensus estimate of $0.22.Revenue, however, fell 3% year-over-year (YoY) to $303.6 million and yet surpassed the $299.36-million consensus estimate.Henry Schuck, ZoomInfo founder and CEO, said, "We continued our move up-market, fueled by ZoomInfo Copilot and Operations growth, and we delivered strong financial results while improving the quality of new customers that we are bringing in.""The entire company is more focused than ever on delighting both our new and existing users via robust product innovation and customer obsession."The company noted that net revenue retention was stable for the third consecutive quarter, as it grew its $100,000 and million-dollar customer cohorts yet again.&nbsp;Looking ahead, the company narrowed its full-year revenue guidance from $1.19 billion-$1.205 billion to $1.201 billion-$1.204 billion. It raised its non-GAAP EPS guidance from $0.86-$0.88 to $0.92-$0.93.&nbsp;Analysts, on average, expect revenue of $1.2 billion and non-GAAP EPS of $0.90.ZoomInfo guided to fourth-quarter revenue of $296 million-$299 million and non-GAAP EPS of $0.22-$0.23. This compares to the consensus estimates of $296.91 million and $0.23, respectively.Following the results, Mizuho raised the price target for the stock from $9 to $11 while maintaining a Neutral rating, the Fly&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://thefly.com/news.php?symbol=ZI">reported.</a> The firm described the quarter as "healthy," and also noted that the management sees small business write-offs abating.&nbsp;The company was seeing traction with its artificial intelligence offerings and the CoPilot solution, especially with mid-market and enterprise segments, the firm added.Retailers on the Stocktwits platform were mixed about the stock. One of them said the company is struggling in one of the best macro environments in history.<stembedurl>https://stocktwits.com/ASAP17/message/592252559</stembedurl>Another termed the stock as a “catch-up play” and noted that the short interest was high.<stembedurl>https://stocktwits.com/Chickenstick1/message/592245466</stembedurl>In premarket trading as of 8:40 am ET, the stock was down a steep 12.84% to $11.40.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/cava-reports-2024-q3-beat-lifts-guidance/cJ4jPR2ROH">CAVA Stock Soars As Tasty Q3 Results Earn Wall Street Cheers, But Retail Appetite Mixed</a>For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>&nbsp;

ZoomInfo said net revenue retention was stable for the third consecutive quarter. 

ZoomInfo Stock Plunges Despite Q3 Beat As Traders Fret Over Shrinking Revenue: Retail Remains Wary

ZoomInfo CEO Schuck said the company is focused on satisfying new and existing customers through product innovation and customer obsession.

Pacer Funds Trust - Pacer US Cash Cows 100 ETF

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

COWZ
Pacer Funds Trust - Pacer US Cash Cows 100 ETF

Feed

News

Sentiment

Fundamentals

Info

Latest COWZ News

COWZPacer Funds Trust - Pacer US Cash Cows 100 ETF